Kamada (KMDA) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Kamada (KMDA) over the past year, gaining 66.2% versus a gain of 18.6%. Over five years, KMDA leads with a +49.7% price change compared with -62.3% for TKNO. Alpha Teknova is the larger company by market cap ($467.6 million vs $455.3 million), about 1.0 times the size.
Kamada pays a dividend yielding 3.17%, while Alpha Teknova does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KMDA | TKNO |
|---|---|---|
| Share price | $7.89 | $8.71 |
| Market cap | $455.33M | $467.62M |
| 1-day change | -2.71% | -0.46% |
| YTD return | +11.76% | +129.21% |
| 1-year return | +18.65% | +66.22% |
| 5-year return | +49.72% | -62.29% |
| P/E ratio (TTM) | 21.32 | — |
| Forward P/E | 13.68 | — |
| EPS (TTM) | $0.37 | $-0.31 |
| Dividend yield | 3.17% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| 52-week high | $9.35 | $9.48 |
| 52-week low | $6.55 | $1.91 |
| Distance from 52-week high | -15.61% | -8.12% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +71.10% | +3.33% |
| Average volume | 118.76K | 230.41K |
| Shares outstanding | 57.71M | 53.69M |
| Employees | 462 | 158 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TKNO has outperformed KMDA by 47.6 percentage points over the past year.
- Kamada offers a meaningfully higher dividend yield (3.17% vs 0.00%).
About Kamada
KMDA stock →Kamada Ltd. manufactures and sells plasma-derived protein therapeutics.
Healthcare · Drug Manufacturers - Specialty & Generic · 462 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
KMDA vs TKNO FAQ
Which is bigger, Kamada or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $467.62M compared with $455.33M for Kamada (KMDA).
Which stock has performed better over the past year, KMDA or TKNO?
TKNO returned +66.22% over the past 12 months, compared with +18.65% for KMDA (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Kamada or Alpha Teknova?
Kamada pays a dividend yielding 3.17%, while Alpha Teknova does not currently pay a regular dividend.
Are Kamada and Alpha Teknova in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.